 Home > Medical News > Medical Research Articles > Keji Pharmaceutical's independent research and development of CAR-T product CT041 was approved for Canadian clinical trial

Keji Pharmaceutical's independent research and development of CAR-T product CT041 was approved for Canadian clinical trial

 Last Update: 2022-01-04
 Source: Internet
 Author: User

Tags

tumor cell markers

1 4 water

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

As of the announcement date, CT041 is the world’s only CAR-T cell immunotherapy that targets CLDN 18.

Dr.

About CT041

CT041 is a potential first-in-class autologous CAR-T cell candidate product targeting CLDN18.

In addition to the trials initiated by researchers in China, Keji Pharmaceuticals also initiated a Phase Ib/II clinical trial for advanced gastric cancer/gastroesophageal junction cancer and pancreatic cancer in China, as well as a phase Ib/II clinical trial in North America.

The latest data from the researcher-initiated trial of CT041 announced at the ESMO conference in 2021 showed that in 18 patients with gastric cancer who had previously failed at least 2 lines of treatment and received the recommended phase II dose (RP2D) 2.

CT041 was awarded the "Orphan Drug" designation by the US FDA in 2020 for the treatment of gastric cancer/gastric esophageal junction cancer.

About Keji Pharmaceutical

Keji Pharmaceutical (stock code: 2171.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Neopentyl Glycol CAS NO.126-30-7 99% High Quality Factory Supply

CAS No.: 126-30-7

Industrial Grade

$1.7-2/KG FOB

Factory Supply Tirzepatide 10 mg 15mg Weight Loss Peptide 10mg 99.9% CAS: 2023788-19-2

CAS No.: 2023788-19-2

Pharmacy Grade

$4-5/UNIT FOB

good quality 2cb wholesale

CAS No.: 58743-75-2

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.